Abiomed
ABMD
#1365
Rank
NZ$29.03 B
Marketcap
NZ$644.00
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Categories
Abiomed is an American medical devices company that develops and manufactures the circulatory support device Impella, the worldโ€™s smallest heart pump.

EPS for Abiomed (ABMD)

EPS in 2022 (TTM): NZ$9.47

According to Abiomed's latest financial reports the company's current EPS (TTM) is NZ$9.94. In 2021 the company made an earnings per share (EPS) of NZ$4.95 a decrease over its 2020 EPS that were of NZ$7.52.

EPS history for Abiomed from 2013 to 2022

Annual EPS

Year EPS Change
2022 (TTM)NZ$9.4791.24%
2021NZ$4.95-34.16%
2020NZ$7.52-18.05%
2019NZ$9.189.48%
2018NZ$8.38141.95%
2017NZ$3.4681.42%
2016NZ$1.91-62.83%
2015NZ$5.14575.56%
2014NZ$0.76125%
2013NZ$0.34

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Boston Scientific
BSX
NZ$4.06-59.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Teleflex
TFX
NZ-$38.54-487.76%๐Ÿ‡บ๐Ÿ‡ธ USA
AtriCure
ATRC
NZ-$0.17-101.70%๐Ÿ‡บ๐Ÿ‡ธ USA